Document Type
Journal Article
Faculty
Faculty of Computing, Health and Science
School
School of Nursing and Midwifery / Clinical Nursing and Midwifery Research Centre
RAS ID
14084
Abstract
There is an absence of sufficient evidence regarding naltrexone use in pregnancy due to the limited range of human studies. Naltrexone implants are being used in Western Australia as a treatment for opioid dependency, and although contraindicated for insertion during pregnancy, there are a number of women who conceive while undergoing treatment. A review of the available data revealed that naltrexone is associated with improved maternal and fetal outcomes. Extensive research into this area in the form of large, multicentre trials is required to confirm the results of the current research.
DOI
10.12968/bjom.2012.20.7.503
Access Rights
free_to_read
Comments
This article was originally published as: Geraghty, S. , & Dixon, C. (2012). The use of naltrexone in pregnancy in opiate-dependent mothers. British Journal of Midwifery, 20(7), 503-506.
This document is the Accepted Manuscript version of a Published Work that appeared in final form in [British Journal of Midwifery], copyright © MA Healthcare, after peer review and technical editing by the publisher. To access the final edited and published work see here